Profile of lacosamide and its role in the long-term treatment of epilepsy: a perspective from the updated NICE guideline
Vanessa Delgado Nunes,1 Laura Sawyer,2 Julie Neilson,1 Grammati Sarri,1 J Helen Cross3,4 1National Clinical Guideline Centre, Royal College of Physicians, London, UK; 2Symmetron Limited, Elstree, UK; 3UCL Institute of Child Health, Great Ormond Street Hospital for Children, London, UK; 4Young Epilep...
Guardado en:
Autores principales: | Delgado Nunes V, Sawyer L, Neilson J, Sarri G, Cross JH |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a6610bba8313454382c479e5b0b59516 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Clinical Efficacy and Safety of Lacosamide as an Adjunctive Treatment in Adults With Refractory Epilepsy
por: Liyan Hou, et al.
Publicado: (2021) -
Lacosamide for the prevention of partial onset seizures in epileptic adults
por: Anna Kelemen, et al.
Publicado: (2010) -
Update on rufinamide in childhood epilepsy
por: Coppola G
Publicado: (2011) -
Update on treatment of partial onset epilepsy: role of eslicarbazepine
por: Markus Rauchenzauner, et al.
Publicado: (2010) -
Update on the role of eslicarbazepine acetate in the treatment of partial-onset epilepsy
por: Tambucci R, et al.
Publicado: (2016)